AstrazenecaAZN
13F holders, Q1 2024 (March 31)4holders
$134.81avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Astrazeneca PLC (AZN) in their 13F filings. The largest holders were Boston Common Asset Management, LLC ($40.4M), Kennedy Capital Management LLC ($5.1M) and Raffa Wealth Management, LLC ($31K).
- Company
- Astrazeneca PLC
- CUSIP
- G0593M107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $5.1M |
| Exits | 0 | $0 |
Ownership 4 holders
| Boston Common Asset Management, LLC | 0.97% | Reduce -0.4% | 299,683 | $40.4M |
| Kennedy Capital Management LLC | 0.10% | New | 37,554 | $5.1M |
| Raffa Wealth Management, LLC | 0.01% | Reduce -3.5% | 464 | $31K |
| Highlander Capital Management, LLC | 0.00% | No change | 84 | $11K |
"% of holder's portfolio" is AZN's weight in each manager's 13F, not the share of Astrazeneca PLC the manager owns.